Report - Sanofi presents Q1 2018 Results · • Bioverativ sales consolidated as of March 9, 2018 •Dupixent sales reached €107m • Strong underlying demand with TRx sequentially up 25%(1)

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form